• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ikaros 对 B 细胞急性淋巴细胞白血病中小 GTPase Rab20 的调控作用。

Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.

机构信息

School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.

College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.

出版信息

Int J Mol Sci. 2020 Mar 3;21(5):1718. doi: 10.3390/ijms21051718.

DOI:10.3390/ijms21051718
PMID:32138279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7084408/
Abstract

Ikaros is a DNA-binding protein that regulates gene expression and functions as a tumor suppressor in B-cell acute lymphoblastic leukemia (B-ALL). The full cohort of Ikaros target genes have yet to be identified. Here, we demonstrate that Ikaros directly regulates expression of the small GTPase, Rab20. Using ChIP-seq and qChIP we assessed Ikaros binding and the epigenetic signature at the RAB20 promoter. Expression of Ikaros, CK2, and was determined by qRT-PCR. Overexpression of Ikaros was achieved by retroviral transduction, whereas shRNA was used to knockdown Ikaros and CK2. Regulation of transcription from the promoter was analyzed by luciferase reporter assay. The results showed that Ikaros binds the promoter in B-ALL. Gain-of-function and loss-of-function experiments demonstrated that Ikaros represses transcription via chromatin remodeling. Phosphorylation by CK2 kinase reduces Ikaros' affinity toward the promoter and abolishes its ability to repress transcription. Dephosphorylation by PP1 phosphatase enhances both Ikaros' DNA-binding affinity toward the promoter and repression. In conclusion, the results demonstrated opposing effects of CK2 and PP1 on expression of Rab20 via control of Ikaros' activity as a transcriptional regulator. A novel regulatory signaling network in B-cell leukemia that involves CK2, PP1, Ikaros, and Rab20 is identified.

摘要

Ikaros 是一种 DNA 结合蛋白,可调节基因表达,并在 B 细胞急性淋巴细胞白血病 (B-ALL) 中作为肿瘤抑制因子发挥作用。Ikaros 的全部靶基因尚未确定。在这里,我们证明 Ikaros 可直接调节小 GTPase Rab20 的表达。我们使用 ChIP-seq 和 qChIP 评估了 Ikaros 结合和 RAB20 启动子上的表观遗传特征。通过 qRT-PCR 测定 Ikaros、CK2 和 的表达。通过逆转录病毒转导实现 Ikaros 的过表达,而 shRNA 用于敲低 Ikaros 和 CK2。通过荧光素酶报告基因分析研究了 启动子转录的调节。结果表明,Ikaros 在 B-ALL 中结合 启动子。功能获得和功能丧失实验表明,Ikaros 通过染色质重塑抑制 转录。CK2 激酶的磷酸化降低了 Ikaros 对 启动子的亲和力,并使其丧失抑制 转录的能力。PP1 磷酸酶的去磷酸化增强了 Ikaros 与 启动子的 DNA 结合亲和力和 抑制作用。总之,结果表明 CK2 和 PP1 通过控制 Ikaros 作为转录调节剂的活性对 Rab20 的表达产生相反的影响。鉴定了涉及 CK2、PP1、Ikaros 和 Rab20 的 B 细胞白血病中的新型调节信号网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/a9bca29cefc5/ijms-21-01718-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/21db1b3abb58/ijms-21-01718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/e0ed72dece26/ijms-21-01718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/d7328c504c34/ijms-21-01718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/ed2bea96a54d/ijms-21-01718-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/40570f8d98b6/ijms-21-01718-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/a9bca29cefc5/ijms-21-01718-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/21db1b3abb58/ijms-21-01718-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/e0ed72dece26/ijms-21-01718-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/d7328c504c34/ijms-21-01718-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/ed2bea96a54d/ijms-21-01718-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/40570f8d98b6/ijms-21-01718-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a1c/7084408/a9bca29cefc5/ijms-21-01718-g006.jpg

相似文献

1
Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.Ikaros 对 B 细胞急性淋巴细胞白血病中小 GTPase Rab20 的调控作用。
Int J Mol Sci. 2020 Mar 3;21(5):1718. doi: 10.3390/ijms21051718.
2
Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.蛋白磷酸酶1(PP1)和酪蛋白激酶II(CK2)调节Ikaros介导的胸腺细胞和T细胞白血病中末端脱氧核苷酸转移酶(TdT)的抑制作用。
Pediatr Blood Cancer. 2014 Dec;61(12):2230-5. doi: 10.1002/pbc.25221. Epub 2014 Sep 11.
3
Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.IKAROS 和蛋白激酶 CK2 对 T 细胞急性淋巴细胞白血病中 PIK3CD 和 PIKFYVE 的转录调控。
Int J Mol Sci. 2021 Jan 15;22(2):819. doi: 10.3390/ijms22020819.
4
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.IKAROS 和 CK2 调节高危 B 细胞急性淋巴细胞白血病中 BCL-XL 的表达和化疗敏感性。
Blood. 2020 Sep 24;136(13):1520-1534. doi: 10.1182/blood.2019002655.
5
Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.酪蛋白激酶II(CK2)和Ikaros对急性淋巴细胞白血病细胞增殖的调控
Adv Biol Regul. 2017 Jan;63:71-80. doi: 10.1016/j.jbior.2016.09.003. Epub 2016 Sep 18.
6
Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.Ikaros、组蛋白去乙酰化酶1(HDAC1)和酪蛋白激酶2(CK2)对B细胞急性淋巴细胞白血病中JARID1B/KDM5B组蛋白去甲基化酶的转录调控
J Biol Chem. 2016 Feb 19;291(8):4004-18. doi: 10.1074/jbc.M115.679332. Epub 2015 Dec 10.
7
Ikaros, CK2 kinase, and the road to leukemia.Ikaros、CK2 激酶与白血病之路。
Mol Cell Biochem. 2011 Oct;356(1-2):201-7. doi: 10.1007/s11010-011-0964-5. Epub 2011 Jul 13.
8
Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.白血病中的蛋白质信号传导与基因转录调控:酪蛋白激酶II - Ikaros轴的作用
J Investig Med. 2016 Mar;64(3):735-9. doi: 10.1136/jim-2016-000075. Epub 2016 Feb 9.
9
Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.Ikaros对BCL6/BACH2轴的调控及其在急性淋巴细胞白血病中的临床意义
Oncotarget. 2017 Jan 31;8(5):8022-8034. doi: 10.18632/oncotarget.14038.
10
High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.在无CRLF2重排的成人急性淋巴细胞白血病中,高CRLF2表达与IKZF1功能障碍相关。
Oncotarget. 2016 Aug 2;7(31):49722-49732. doi: 10.18632/oncotarget.10437.

引用本文的文献

1
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.IKAROS和HDAC1在T细胞急性淋巴细胞白血病中对异染色质调控及肿瘤抑制的关键作用
Leukemia. 2025 Jun 24. doi: 10.1038/s41375-025-02651-1.
2
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?IKAROS 在急性白血病中的作用:正面影响者还是恶意攻击者?
Int J Mol Sci. 2023 Feb 7;24(4):3282. doi: 10.3390/ijms24043282.
3
Ikaros Proteins in Tumor: Current Perspectives and New Developments.肿瘤中的Ikaros蛋白:当前观点与新进展

本文引用的文献

1
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.慢性髓性白血病疾病进展和酪氨酸激酶抑制剂治疗耐药的机制:最新进展。
Int J Mol Sci. 2019 Dec 5;20(24):6141. doi: 10.3390/ijms20246141.
2
high expression associated with dysfunction in adult B-cell acute lymphoblastic leukemia.高表达与成人B细胞急性淋巴细胞白血病功能障碍相关。
J Cancer. 2019 Jun 9;10(16):3842-3850. doi: 10.7150/jca.33989. eCollection 2019.
3
Next-Generation Sequencing in Acute Lymphoblastic Leukemia.
Front Mol Biosci. 2021 Dec 7;8:788440. doi: 10.3389/fmolb.2021.788440. eCollection 2021.
4
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.双重靶向 MTOR 作为高危 B 细胞急性淋巴细胞白血病的一种新治疗方法。
Leukemia. 2021 May;35(5):1267-1278. doi: 10.1038/s41375-021-01132-5. Epub 2021 Feb 2.
急性淋巴细胞白血病中的二代测序。
Int J Mol Sci. 2019 Jun 15;20(12):2929. doi: 10.3390/ijms20122929.
4
Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.鉴定和描述具有潜在临床应用价值的新型融合基因在墨西哥儿童急性淋巴细胞白血病中的作用。
Int J Mol Sci. 2019 May 15;20(10):2394. doi: 10.3390/ijms20102394.
5
Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.Ikaros 肿瘤抑制功能包括诱导活性增强子和超级增强子以及启动活性。
Leukemia. 2019 Nov;33(11):2720-2731. doi: 10.1038/s41375-019-0474-0. Epub 2019 May 9.
6
Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia.急性淋巴细胞白血病中异常的ARID5B表达及其与Ikaros功能障碍的关联。
Oncogenesis. 2018 Nov 12;7(11):84. doi: 10.1038/s41389-018-0095-x.
7
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.自噬抑制作为 ETV6-RUNX1 驱动的 B 细胞前体急性淋巴细胞白血病的潜在未来靶向治疗。
Haematologica. 2019 Apr;104(4):738-748. doi: 10.3324/haematol.2018.193631. Epub 2018 Oct 31.
8
Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics.蛋白磷酸酶 1 的功能和治疗潜力:来自小鼠遗传学的见解。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):16-30. doi: 10.1016/j.bbamcr.2018.07.019. Epub 2018 Jul 26.
9
Protein phosphatases in chromatin structure and function.染色质结构与功能中的蛋白磷酸酶。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):90-101. doi: 10.1016/j.bbamcr.2018.07.016. Epub 2018 Jul 20.
10
Molecular Regulation of Differentiation in Early B-Lymphocyte Development.早期 B 淋巴细胞发育中分化的分子调控。
Int J Mol Sci. 2018 Jun 30;19(7):1928. doi: 10.3390/ijms19071928.